RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis

INTRODUCTION: Radiotherapy (RT) is currently the main treatment for brain metastases (BMs) from non-small cell lung cancer (NSCLC). Due to the short survival time and obvious adverse reactions of RT, we urgently need more appropriate treatment. This network meta-analysis reviewed the efficacy and ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Min, Jiang, Jun, Zhang, Xuewen, Chen, Jie, Chang, Qiaomei, Chen, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744133/
https://www.ncbi.nlm.nih.gov/pubmed/36518310
http://dx.doi.org/10.3389/fonc.2022.1024833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744133/
https://www.ncbi.nlm.nih.gov/pubmed/36518310
http://dx.doi.org/10.3389/fonc.2022.1024833

Ejemplares similares